Research unit on cardiovascular and metabolic diseases
The research unit UMR_S 1166 is situated in the heart of the University Hospital at the Pitié-Salpêtrière, which is one of the largest hospitals in Europe. UMR_S 1166 was established January 1, 2014 and renewed January 1, 2019 for a 5 year period with INSERM and Sorbonne Université in Paris.
It brings together 5 internationally recognized research teams with complementary interests and approaches in genetics, genomics, bioinformatics, molecular and cellular biology, physiology and pharmacology to bear upon cardiovascular and metabolic diseases. These teams are grouped together in the Medical School located at 91 boulevard de l’Hôpital in Paris.
Cardiovascular and metabolic diseases are the principal cause of mortality in developed countries highlighting the need for a concerted effort to confront this problem. These diseases share certain pathophysiological characteristics including diet, lifestyle, environment, genetic and epigenetic factors that contribute to disease progression and that are also the initial cause. The UMR_S 1166 is founded on the idea that interactions between basic and clinical research is critical for future progress in understanding these diseases.
The teams of the research unit UMR_S 1166, associated with team of the research centers Saint-Antoine and Les Cordeliers, are members of the Institute of Cardiometabolism And Nutrition IHU ICAN.